US Stock MarketDetailed Quotes
BIAF bioAffinity Technologies
- 1.910
- -0.020-1.04%
Close Oct 11 16:00 ET
- 1.837
- -0.074-3.85%
Post 20:02 ET
25.77MMarket Cap-2098P/E (TTM)
1.940High1.850Low26.02KVolume1.860Open1.930Pre Close49.69KTurnover0.38%Turnover RatioLossP/E (Static)13.49MShares3.62052wk High7.52P/B13.26MFloat Cap1.15052wk Low--Dividend TTM6.94MShs Float15.550Historical High--Div YieldTTM4.66%Amplitude0.955Historical Low1.910Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
bioAffinity Technologies Stock Forum
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that CyPath® Lung, its noninvasive test to detect early-stage lung cancer, will be added to the U.S. Federal Supply Schedule, a procurement system that provides the...
bioAffinity Technologies, a leading player in the field of early cancer detection, recently reported an acceleration in sales growth of its revolutionary product, CyPath® Lung. This surge signifies a growing demand for innovative, non-invasive methods for early lung cancer detection and highlights the potential of CyPath® Lung to revolutionize the i...
No comment yet